Research Projects All Projects
Projects

Quick links

Direction Name Project leader Period Funding
Cancer research
Understanding the biology of the minimal residual disease after targeted therapy of BRAF mutant melanoma Dace Pjanova 2019.03.01.-2022.02.28. ERDF

Role of natural killer cells in the therapeutic efficacy of oncolytic measles virus Rūta Veinalde 2018.10.01-2021.09.30 ERDF
Human genetics and disease mechanisms
Molecular design of new luminescent compounds for diagnostic purposes Dace Pjanova 2017.03.01.-2020.02.29. ERDF
Cancer research
Immunomodulating properties of bacteriophage derived dsRNA of different size and their use as vaccine adjuvants Dace Pjanova 2016-2018 Taiwan-Latvian-Lithuanian collaboration project
Human genetics and disease mechanisms
Cancer research
Identification of genetic markers involved in development of metastases and second cancers in melanoma (GENMEL) Dace Pjanova 2015.05.01.-2018.04.30. ERA-NET
Human genetics and disease mechanisms
Cancer research
Development of novel in vitro tests for diagnostics and prognostics of individualized therapies of tumors and mitochondrial disease treatment Jānis Kloviņš 2014.08.01.-2015.08.31. ERDF
Cancer research
molecular pharmacology and drug targets
Development of novel anticancer drugs and immunotherapeutic approaches Aija Linē 2014-2017 SRP
Cancer research
Regulation of self-renewal and senescence in the DNA damaged tumour cells Jekaterina Ērenpreisa 2013-2016 LCS
Cancer research
Research of anti-tumor resistance molecular and cellular mechanisms Jekaterina Ērenpreisa 2013-2015 (01.10.13-31.08.15) ESF
Cancer research
Development of anticancer drugs targeting cancer stem-like cells Jekaterina Ērenpreisa , Aija Linē 2010-2014 SRP
Cancer research
Prognostic testing for assessment of the effectiveness of immunotherapeutic drugs: method for personalized drug usage in oncology Dace Pjanova 2010-2013 ERDF
Human genetics and disease mechanisms
Biotechnology and structural biology
Molecular microbiology and virology
Cancer research
The investigation of molecular and genetic mechanisms of pathogenesis and the development of novel means for diagnosis and therapy Kaspars Tārs 2010-2012 ESF
Cancer research
The molecular genetic alterations in the development of malignant skin melanoma in Latvia Dace Pjanova 2009-2010 EEA
Cancer research
The role of MC1R gene variants in melanoma development in patients without alterations in CDKN2A and CDK4 genes Olita Heisele 2007-2008 LCS GR
Cancer research
Novel tools for screening of anti-cancer compounds Jekaterina Ērenpreisa 2006-2009 LCS GR
1 2


Mājas lapas izstrādi finansēja ERAF 2.1.1.2. aktivitātes projekts Nr. 2010/0196/2DP/2.1.1.2.0/10/APIA/VIAA/004 "Latvijas biomedicīnas pētījumu integrācija Eiropas zinātnes telpā".